http://www.foreignpolicy.com/issue_mayjune_2001/hotez.html
The multinational effort to eliminate disease might not
only save lives but prevent conflict.
Vaccines are arguably one of humankind’s greatest
creations. Because of vaccines’ remarkable ability to halt great plagues and
eliminate disease, few other peacetime inventions have had as much influence on
human history. Within the last 20 years alone, vaccines have eradicated
smallpox, with polio soon to follow. But inoculations that eliminate disease
could have an impact well beyond improving global health. Throughout the
developing world, vaccines could also be transformed into powerful agents of
conflict resolution.
Vaccine diplomacy is nearly as old as vaccines themselves.
In 1798, British doctor Edward Jenner published his research on the use of the cowpox
(vaccinia) virus to vaccinate (from the Latin word for cow) against the human
smallpox virus. By 1800, the Jenner smallpox vaccine was used widely in England
and shipped across the channel to France. Within a decade, Napoleon decreed
that vaccine departments should be established in all of the major cities of
the French empire. And in 1811 Jenner was elected as a foreign member of the Institute
of France. Strikingly, Jenner’s participation in the use and development of the
smallpox vaccine in France occurred during a time of almost continuous war
between England and France. But, as Jenner himself observed in a letter to the
National Institute of France, “The sciences are never at war.”
Similarly, in the early 1950s, polio epidemics raged on
both sides of the Iron Curtain. The dreadful nature of these epidemics (they
struck young children particularly hard) could have been the deciding factor in
compelling the Soviets to break their Cold War silence in 1956 when they
realized, in the words of medical historian Saul Benison, “they could no longer
afford the comfort and sustenance that ideology provided.” Soviet virologists
subsequently collaborated with U.S. researcher Albert Sabin to develop a “live”
polio vaccine that improved upon the one developed by Jonas Salk in 1954. To
this day, many Americans are astonished to learn that the Sabin polio vaccine was
introduced into the United States only after its safety and efficacy had first
been tested in millions of Soviet children.
The legacy of Cold War vaccine diplomacy is now felt in
polio-endemic regions of Africa and Central Asia where, during the last five
years, the United Nations Children’s Fund and the World Health Organization have
negotiated cease-fires in order to conduct successful polio immunization
campaigns. Through the efforts of United Nations agencies, mass vaccinations
during so-called days of tranquility have been brokered every year in
Afghanistan since 1993. In Sudan, former U.S. President Jimmy Carter helped
negotiate a six-month cease-fire in 1995 to reduce the incidence of
drancunculiasis, a parasitic disease caused by the guinea worm. (The “guinea
worm cease-fire” was, at that time, the longest cease-fire in the history of
the Sudanese civil conflict.) National immunization days also temporarily
halted hostilities in Sierra Leone.
Today, the part of the world most in need of both vaccines
and diplomacy is South Asia. Three years ago, the Indian government renewed
underground nuclear testing in part because of a perceived threat from China.
But India and China share more than a disputed border and expanding nuclear capabilities:
These two nations, which together comprise approximately 40 percent of the
world’s population, also share one of the highest rates of tropical infectious
diseases. Illnesses caused by animal
parasites living in the human intestine are especially endemic to the region.
Diagnostic surveys conducted by the Chinese Ministry of Health between 1988 and
1992 revealed more than 500 million cases of ascariasis (an infection caused by
a large intestinal roundworm), 212 million cases of whipworm infection, and 194
million cases of hookworm infection. India is equally plagued by these
parasites, which cause devastating problems among both children and adults,
especially pregnant women.
The technology exists to make a vaccine to control worms
in India and China, but the resources available for this task are pathetically meager.
Despite the enormous burdens of disease, both nations still spend much of their
scientific budget on the physical and mathematical sciences necessary to develop
nuclear arsenals. If these nations diverted even one tenth of their
nuclear-weapons budgets to vaccine research, diseases like hookworm might be
eradicated in the 21st century. Now is the time to advocate a new
peacetime mission for the Chinese and Indian scientific communities—to shift
their intellects and their resources to eradicating the infections that currently
trap their rural citizens in a perpetual cycle of poverty. As Sonia Gandhi, the leader of the Congress
Party (and daughter-in-law of former Prime Minister Indira Gandhi), remarked, “science
should be used for removing poverty and backwardness in the country.”
A multilateral vaccine development program that focuses on
tropical infectious diseases highly endemic to South and East Asia might foster
a spirit of regional cooperation. Such a program would draw scientists and
government health officials from countries engaged in nuclear saber rattling
together for a common cause. Moreover, this effort could serve as a model to
cope with the next health crisis that will soon ravage the region. Although
much of the media coverage of HIV/AIDS has focused on Africa, a newer and
possibly more frightening HIV/AIDS epidemic has started to roll through densely
populated areas of the Indian subcontinent and China. Through government
agencies and private foundations, developed countries can commit critical
resources to accelerate the development of new vaccines. Along the way, we
might acquire an immunity to war.
Peter J. Hotez is chair of the Department of Microbiology
and Tropical Medicine at George Washington University and a senior fellow of
the Albert B. Sabin Vaccine Institute, where he is principal investigator of
the Human Hookworm Vaccine Initiative.
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.